• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及三家重症监护病房与导管相关血流感染相关的耐碳青霉烯类革兰氏阴性菌。

Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt.

机构信息

Microbiology and Immunology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.

Microbiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.

出版信息

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1647-1652. doi: 10.1007/s10096-018-3294-7. Epub 2018 Jun 23.

DOI:10.1007/s10096-018-3294-7
PMID:29936619
Abstract

We aimed to identify the carbapenem-resistant Gram-negative bacteria (GNB) causing catheter-related bloodstream infections (CRBSI) in intensive care units (ICU) in a tertiary care Egyptian hospital, to study their resistance mechanisms by phenotypic and genetic tests, and to use ERIC-PCR for assessing their relatedness. The study was conducted over 2 years in three ICUs in a tertiary care hospital in Egypt during 2015-2016. We identified 194 bloodstream infections (BSIs); 130 (67.01%) were caused by GNB, of which 57 were isolated from CRBSI patients (73.84%). Identification of isolates was performed using conventional methods and MALDI-TOF MS. Antimicrobial susceptibility testing (AST) was done by disc diffusion following CLSI guidelines. Phenotypic detection of carbapenemases enzymes activity was by modified Hodge test and the Carba-NP method. Isolates were investigated for the most common carbapenemases encoding genes bla, bla, and bla using multiplex PCR. Molecular typing of carbapenem-resistant isolates was done by ERIC-PCR followed by sequencing of common resistance genes. The overall rate of CRBSI in our study was 3.6 per 1000 central venous catheter (CVC) days. Among 57 Gram-negative CRBSI isolates, Klebsiella pneumoniae (K. pneumoniae) was the most frequently isolated (27/57; 47.4%), of which more than 70% were resistant to Meropenem. Phenotypic tests for carbapenemases showed that 37.9% of isolates were positive by modified Hodge test and 63.8% by Carba-NP detection. Multiplex PCR assay detected the bla in 28.6% of the isolates and bla in 26.8%, bla and bla were detected together in the same isolate in 5.6%, while bla-like were not detected. ERIC-PCR detected limited genetic relatedness between K. pneumoniae isolates. Elevated resistance rates were observed to all antibiotics including carbapenems among K. pneumoniae isolates causing CRBSI. ERIC-PCR showed that the resistant isolates were mainly polyclonal. Our results call for reinforcement of antimicrobial stewardship and measures to prevent CRBSI.

摘要

我们旨在鉴定引起埃及一家三级护理医院重症监护病房(ICU)导管相关血流感染(CRBSI)的耐碳青霉烯类革兰氏阴性菌(GNB),通过表型和基因检测研究其耐药机制,并使用 ERIC-PCR 评估其相关性。该研究于 2015-2016 年在埃及一家三级护理医院的三个 ICU 进行了 2 年。我们鉴定了 194 例血流感染(BSI);130 例(67.01%)由 GNB 引起,其中 57 例从 CRBSI 患者中分离(73.84%)。使用常规方法和 MALDI-TOF MS 进行分离物鉴定。根据 CLSI 指南进行药敏试验(AST)。通过改良 Hodge 试验和 Carba-NP 方法检测碳青霉烯酶活性。使用多重 PCR 检测最常见的碳青霉烯酶编码基因 bla、bla 和 bla。对耐碳青霉烯的分离株进行 ERIC-PCR 分子分型,然后对常见耐药基因进行测序。耐碳青霉烯分离株的总体 CRBSI 发生率为每 1000 个中心静脉导管(CVC)天 3.6 例。在 57 株革兰氏阴性 CRBSI 分离株中,肺炎克雷伯菌(K. pneumoniae)是最常分离的(27/57;47.4%),其中超过 70%对美罗培南耐药。碳青霉烯酶表型检测显示,改良 Hodge 试验阳性率为 37.9%,Carba-NP 检测阳性率为 63.8%。多重 PCR 检测发现 28.6%的分离株携带 bla,26.8%的分离株携带 bla,同一分离株同时携带 bla 和 bla 的比例为 5.6%,而 bla 样基因未检出。ERIC-PCR 检测到肺炎克雷伯菌分离株之间遗传相关性有限。引起 CRBSI 的肺炎克雷伯菌对所有抗生素包括碳青霉烯类的耐药率均升高。ERIC-PCR 显示,耐药分离株主要为多克隆。我们的结果呼吁加强抗菌药物管理和预防 CRBSI 的措施。

相似文献

1
Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt.埃及三家重症监护病房与导管相关血流感染相关的耐碳青霉烯类革兰氏阴性菌。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1647-1652. doi: 10.1007/s10096-018-3294-7. Epub 2018 Jun 23.
2
Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.从阿尔及利亚南部瓦尔格拉的穆罕默德·布迪亚夫大学医院分离的耐碳青霉烯类革兰氏阴性菌的遗传特征。
J Glob Antimicrob Resist. 2017 Mar;8:55-59. doi: 10.1016/j.jgar.2016.10.008. Epub 2016 Dec 19.
3
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.来自泰国曼谷的产碳青霉烯酶的耐碳青霉烯类肠杆菌科细菌及其通过Carba NP和改良碳青霉烯灭活方法试验的检测。
Microb Drug Resist. 2018 Sep;24(7):1006-1011. doi: 10.1089/mdr.2018.0080. Epub 2018 May 21.
4
[Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].[产超广谱β-内酰胺酶(ESBL)的肠杆菌科分离株引起侵袭性感染时对碳青霉烯类抗生素的耐药性]
Mikrobiyol Bul. 2014 Jan;48(1):59-69.
5
Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.长期住院患者中碳青霉烯类耐药革兰阴性杆菌的微生物感染模式、致病特征和耐药机制。
Microb Pathog. 2018 Apr;117:356-360. doi: 10.1016/j.micpath.2018.02.025. Epub 2018 Feb 13.
6
High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt.来自埃及单一三级护理中心的产不同 NDM 型和其他碳青霉烯酶等位基因的肺炎克雷伯菌临床分离株的高危克隆和新型序列型 ST4497。
Int J Antimicrob Agents. 2020 Dec;56(6):106164. doi: 10.1016/j.ijantimicag.2020.106164. Epub 2020 Sep 16.
7
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
8
Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu.来自泰米尔纳德邦的耐碳青霉烯革兰氏阴性菌的特征分析。
J Chemother. 2016 Oct;28(5):371-4. doi: 10.1179/1973947815Y.0000000056. Epub 2016 Jul 22.
9
[Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].[临床肺炎克雷伯菌分离株中碳青霉烯酶产生检测的表型方法与聚合酶链反应的比较]
Mikrobiyol Bul. 2017 Jul;51(3):269-276. doi: 10.5578/mb.57333.
10
Emergence of Multidrug-Resistant New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae in Egypt.埃及产新型耐多药新德里金属β-内酰胺酶-1肺炎克雷伯菌的出现。
Microb Drug Resist. 2017 Jun;23(4):480-487. doi: 10.1089/mdr.2016.0003. Epub 2016 Aug 30.

引用本文的文献

1
Prevalence, trends, and molecular insights into colistin resistance among gram-negative bacteria in Egypt: a systematic review and meta-analysis.埃及革兰氏阴性菌中黏菌素耐药性的流行情况、趋势及分子见解:一项系统综述和荟萃分析
Ann Clin Microbiol Antimicrob. 2025 May 10;24(1):32. doi: 10.1186/s12941-025-00799-3.
2
Phenotypic and genotypic characterization of carbapenemase-producing clinical isolates in Thi-Qar, Iraq.伊拉克济加尔省产碳青霉烯酶临床分离株的表型和基因型特征
Iran J Microbiol. 2025 Apr;17(2):268-277. doi: 10.18502/ijm.v17i2.18387.
3
Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A .

本文引用的文献

1
Epidemiological typing of multidrug-resistant Klebsiella pneumoniae, which causes paediatric ventilator-associated pneumonia in Egypt.引起埃及儿童呼吸机相关性肺炎的多重耐药肺炎克雷伯菌的流行病学分型
J Med Microbiol. 2017 May;66(5):628-634. doi: 10.1099/jmm.0.000473. Epub 2017 May 9.
2
Phenotypic and molecular detection of the bla gene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil.巴西马塞约州圣路易斯市医院住院患者临床分离株中bla基因的表型和分子检测
BMC Infect Dis. 2016 Dec 7;16(1):737. doi: 10.1186/s12879-016-2072-3.
3
International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module.
在非洲实施世界卫生组织全球抗微生物药物敏感性监测系统(WHO-GLASS)关于优先病原体-抗生素敏感性检测建议的进展:A.
Wellcome Open Res. 2024 Nov 22;9:692. doi: 10.12688/wellcomeopenres.23133.1. eCollection 2024.
4
Genomic dynamics of high-risk carbapenem-resistant klebsiella pneumoniae clones carrying hypervirulence determinants in Egyptian clinical settings.埃及临床环境中携带超毒力决定因子的高风险碳青霉烯类耐药肺炎克雷伯菌克隆的基因组动态。
BMC Infect Dis. 2024 Oct 22;24(1):1193. doi: 10.1186/s12879-024-10056-1.
5
Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.肯尼亚重症监护病房耐碳青霉烯类革兰氏阴性菌感染及获得的危险因素。
BMC Infect Dis. 2024 May 23;24(1):522. doi: 10.1186/s12879-024-09256-6.
6
Carbapenem- and colistin-resistant in intensive care unit patients in Mediterranean countries, 2019.2019年地中海国家重症监护病房患者对碳青霉烯类和黏菌素的耐药情况
Front Microbiol. 2024 Apr 12;15:1370553. doi: 10.3389/fmicb.2024.1370553. eCollection 2024.
7
Mutation-based fluoroquinolone resistance in carbapenem-resistant and isolates causing catheter-related bloodstream infections.耐碳青霉烯类且导致导管相关血流感染的分离株中基于突变的氟喹诺酮耐药性
Int J Health Sci (Qassim). 2023 May-Jun;17(3):18-25.
8
Genotyping and molecular investigation of plasmid-mediated carbapenem resistant clinical isolates in Egypt.埃及质粒介导的碳青霉烯耐药临床分离株的基因分型与分子研究
AIMS Microbiol. 2023 Mar 23;9(2):228-244. doi: 10.3934/microbiol.2023014. eCollection 2023.
9
Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa.非洲耐碳青霉烯类和多黏菌素类大肠埃希菌和肺炎克雷伯菌重叠威胁的回顾与分析。
Antimicrob Resist Infect Control. 2023 Apr 4;12(1):29. doi: 10.1186/s13756-023-01220-4.
10
Occurrence and Molecular Study of Hypermucoviscous/Hypervirulence Trait in Gut Commensal from Healthy Subjects.健康受试者肠道共生菌中高黏液性/高毒力特性的发生及分子研究
Microorganisms. 2023 Mar 9;11(3):704. doi: 10.3390/microorganisms11030704.
国际医院感染控制联盟报告,2010 - 2015年50个国家的数据总结:器械相关模块
Am J Infect Control. 2016 Dec 1;44(12):1495-1504. doi: 10.1016/j.ajic.2016.08.007. Epub 2016 Oct 11.
4
National surveillance of health care-associated infections in Egypt: Developing a sustainable program in a resource-limited country.埃及医疗保健相关感染的国家监测:在资源有限的国家制定可持续计划。
Am J Infect Control. 2016 Nov 1;44(11):1296-1301. doi: 10.1016/j.ajic.2016.04.212. Epub 2016 Jun 20.
5
A Point Prevalence Survey of Antibiotic Use in 18 Hospitals in Egypt.埃及 18 家医院抗生素使用的时点调查。
Antibiotics (Basel). 2014 Sep 10;3(3):450-60. doi: 10.3390/antibiotics3030450.
6
Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria.重症监护病房患者的血流感染:细菌分布及抗生素耐药性
Infect Drug Resist. 2015 Aug 10;8:287-96. doi: 10.2147/IDR.S48810. eCollection 2015.
7
Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Turkey.从土耳其一家三级医院的携带者和临床样本中分离出的耐万古霉素粪肠球菌菌株的分子特征
J Med Microbiol. 2015 Jul;64(7):759-766. doi: 10.1099/jmm.0.000088. Epub 2015 May 14.
8
Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program.应对重症监护中的耐药性:西班牙重症监护病房“零耐药”项目的多模式方法。
Crit Care. 2015 Mar 16;19(1):114. doi: 10.1186/s13054-015-0800-5.
9
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.移植受者和血液系统恶性肿瘤患者中耐碳青霉烯类肠杆菌科细菌的全球挑战。
Clin Infect Dis. 2014 May;58(9):1274-83. doi: 10.1093/cid/ciu052. Epub 2014 Jan 23.
10
The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia.沙特阿拉伯利雅得出现产 OXA-48 和 NDM-1 型阳性肺炎克雷伯菌。
Int J Infect Dis. 2013 Dec;17(12):e1130-3. doi: 10.1016/j.ijid.2013.06.016. Epub 2013 Aug 30.